DrugPatentWatch Database Preview
Drugs in MeSH Category Neuroprotective Agents
Email this page to a colleague
» See Plans and Pricing| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Noveltech Inc | RIVASTIGMINE | rivastigmine | FILM, EXTENDED RELEASE;TRANSDERMAL | 206318-002 | Mar 4, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Mylan Technologies | RIVASTIGMINE | rivastigmine | FILM, EXTENDED RELEASE;TRANSDERMAL | 205622-003 | Jun 20, 2018 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Pharmacia And Upjohn | MEDROL | methylprednisolone | TABLET;ORAL | 011153-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| Covis Pharma Bv | RILUTEK | riluzole | TABLET;ORAL | 020599-001 | Dec 12, 1995 | AB | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
